Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, giving promising developments across different healthcare and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, a lot more trustworthy substitute for therapeutic use, special